Evaluation of Fluorodeoxyglucose Positron Emission Tomography Imaging in Metastatic Transitional Cell Carcinoma with and without Prior Chemotherapy

Publisher： Karger

E-ISSN： 1423-0399|77|1|69-75

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.77, Iss.1, 2009-05, pp. : 69-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospective evaluation of 18F‐fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases

By  

HPB, Vol. 17, Iss. 7, 2015-07 ,pp. : 644-650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Somatostatin receptor positron emission tomography/computed tomography imaging in Merkel cell carcinoma

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 30, Iss. 9, 2016-09 ,pp. : 1507-1511

John Wiley & Sons Inc

Access to resources Recommend Favorite

Positron Emission Tomography for Neck Evaluation Following Definitive Treatment with Chemoradiotherapy for Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

By  

Reviews on Recent Clinical Trials, Vol. 7, Iss. 1, 2012-02 ,pp. : 36-41

Bentham Science Publishers

Access to resources Recommend Favorite

Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Detecting Extrahepatic Metastasis in Pretreatment Staging of Hepatocellular Carcinoma

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 104-110

Karger

Access to resources Recommend Favorite

The Standardized Uptake Value of 18-Fluorodeoxyglucose Positron Emission Tomography after Chemoradiation and Clinical Outcome in Patients with Localized Gastroesophageal Carcinoma

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 316-322

Karger

Access to resources Recommend Favorite